Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2013

Jun 27, 2013

30320_dirs_2013-06-27_33030549-0979-4e78-b20e-138533bd721f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2013-06-26

Reporting Person: KURZWEIL RAY (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-06-26 Share Tracking Award $63.90 A 15000 Acquired 2023-06-26 Common Stock (15000) Direct

Footnotes

F1: Annual non-employee director grant of cash-settled share tracking awards, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.

F2: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.